Listar por autor "Gómez-Otero, Inés"
Mostrando ítems 1-4 de 4
-
Beta-blocker exposure and survival in patients with transthyretin amyloid cardiomyopathy
Barge-Caballero, Gonzalo; Barge-Caballero, Eduardo; López-Pérez, Manuel; Bilbao-Quesada, Raquel; González-Babarro, Eva; Gómez-Otero, Inés; López-López, Andrea; Gutiérrez-Feijoo, Mario; Varela-Román, Alfonso; González-Juanatey, Carlos; Díaz-Castro, Óscar; Crespo-Leiro, María Generosa (Elsevier, 2022-02)[Abstract] Objective: To investigate a potential association between beta-blocker exposure and survival in patients with transthyretin amyloid cardiomyopathy (ATTR-CM). Methods: In this real-world prospective registry ... -
Cardiac amyloidosis: description of a series of 143 cases
Barge-Caballero, Gonzalo; Barge-Caballero, Eduardo; López-Pérez, Manuel; Bilbao-Quesada, Raquel; González-Babarro, Eva; Gómez-Otero, Inés; López-López, Andrea; Gutiérrez-Feijoo, Mario; Varela-Román, Alfonso; González-Juanatey, Carlos; Díaz-Castro, Óscar; Crespo-Leiro, María Generosa (Elsevier, 2022-09-09)[Abstract] Introduction and objectives: Recently, there have been important advances in the diagnosis and treatment of cardiac amyloidosis (CA). Our aim was to provide an updated description of its 2 most frequent types: ... -
Prevalence, incidence, and outcomes of hyperkalaemia in patients with chronic heart failure and reduced ejection fraction from a spanish multicentre study: SPANIK-HF design and baseline characteristics
Delgado-Jiménez, Juan F.; Segovia-Cubero, Javier; Almenar-Bonet, Luis; Juan-Bagudá, Javier de; Lara-Padrón, Antonio; García-Pinilla, José Manuel; Bonilla-Palomas, Juan Luis; López-Fernández, Silvia; Mirabet-Pérez, Sonia; Gómez-Otero, Inés; Castro-Fernández, Antonio; Díaz-Molina, Beatriz; Goirigolzarri-Artaza, Josebe; Rincón-Pérez, Luis Miguel; Pascual-Figal, Domigo A.; Anguita-Sánchez, Manuel; Muñiz, Javier; Crespo-Leiro, María Generosa (MDPI, 2022-02-22)[Abstract] Hyperkalaemia is a growing concern in the treatment of patients with heart failure and reduced ejection fraction (HFrEF) as it limits the use of some prognostic-modifying drugs and has a negative impact on ... -
Syncope in patients with transthyretin amyloid cardiomyopathy: clinical features and outcomes
Barge-Caballero, Gonzalo; Barge-Caballero, Eduardo; López-Pérez, Manuel; Bilbao-Quesada, Raquel; González-Babarro, Eva; Gómez-Otero, Inés; López-López, Andrea; Gutiérrez-Feijoo, Mario; Varela-Román, Alfonso; González-Juataney, Carlos; Díaz-Castro, Óscar; Crespo-Leiro, María Generosa (Taylor & Francis, 2022-03-23)[Abstract] Background: We aimed to describe the clinical characteristics, underlying causes and outcomes of syncope in patients with transthyretin amyloid cardiomyopathy (ATTR-CM). Methods: The clinical profile and ...